Leerink Partnrs Has Bearish Outlook for Danaher Q1 Earnings

Danaher Co. (NYSE:DHRFree Report) – Leerink Partnrs cut their Q1 2025 EPS estimates for shares of Danaher in a research report issued on Wednesday, December 11th. Leerink Partnrs analyst P. Souda now forecasts that the conglomerate will post earnings per share of $2.02 for the quarter, down from their previous estimate of $2.06. The consensus estimate for Danaher’s current full-year earnings is $7.50 per share. Leerink Partnrs also issued estimates for Danaher’s Q2 2025 earnings at $1.88 EPS, Q3 2025 earnings at $1.86 EPS, Q4 2025 earnings at $2.46 EPS, FY2025 earnings at $8.22 EPS and FY2026 earnings at $9.22 EPS.

Danaher (NYSE:DHRGet Free Report) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same quarter in the previous year, the business earned $2.02 earnings per share. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year.

Other equities research analysts have also issued research reports about the stock. Evercore ISI lifted their price objective on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a report on Friday. Raymond James reduced their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. UBS Group lowered their target price on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Finally, Robert W. Baird decreased their price objective on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $287.95.

Get Our Latest Research Report on DHR

Danaher Stock Down 0.2 %

NYSE:DHR opened at $234.36 on Monday. The stock has a fifty day simple moving average of $246.23 and a 200-day simple moving average of $257.30. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a market cap of $169.27 billion, a price-to-earnings ratio of 44.72, a price-to-earnings-growth ratio of 4.33 and a beta of 0.83. Danaher has a twelve month low of $222.53 and a twelve month high of $281.70.

Hedge Funds Weigh In On Danaher

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Fort Pitt Capital Group LLC lifted its holdings in shares of Danaher by 3.2% in the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after buying an additional 7,421 shares during the period. Good Life Advisors LLC acquired a new position in Danaher in the third quarter valued at approximately $217,000. Oak Thistle LLC purchased a new stake in Danaher in the 2nd quarter worth approximately $363,000. Harvest Portfolios Group Inc. grew its stake in shares of Danaher by 1.2% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after purchasing an additional 2,465 shares during the period. Finally, Stifel Financial Corp increased its holdings in shares of Danaher by 1.3% during the 3rd quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock valued at $235,583,000 after purchasing an additional 11,216 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Danaher Company Profile

(Get Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Recommended Stories

Earnings History and Estimates for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.